Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesNeuroendocrine tumors of the pancreas
The Oncologist, 07/27/09
Ehehalt F et al. - Main objectives of literature review are:
- Assess the basic aspects of pancreatic neuroendocrine tumors (PNET) tumor biology, pathogenesis, and classification
- Explain the epidemiology and evaluate the prognosis of PNET pts
- Engage in rational clinical management of PNETs
- PNETs display variable malignant potential, hormone-related syndromes (functionality), localization, and genetic background
- Optimal clinical management of PNETs involves a multidisciplinary approach:
- Surgery remains the only curative treatment for early-stage disease
- Alternative therapeutic approaches including:
- chemotherapy, radiofrequency ablation, transarterial chemoembolization
- biotherapy, polypeptide radionuclide receptor therapy
- antiangiogenic therapy, and selective internal radiotherapy
have failed to demonstrate a long-term survival benefit
- Research on PNETs is needed to improve the therapeutic options for pts with this disease
Today in Endocrine Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
Thyroid, 10/30/09
Thyroid lymphoma and airway obstruction – is there a rationale for surgical management?
International Journal of Clinical Practice, 10/19/09
Thyroid Cancer in Systemic Lupus Erythematosus: A Case-Control Study
Journal of Clinical Endocrinology and Metabolism, 11/12/09
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
High-risk neuroblastoma: a therapy in evolution
Pediatric Hematology and Oncology, 11/30/09
Critical appraisal of temozolomide formulations in the treatment of primary brain tumors: patient considerations
Cancer Management and Research, 11/05/09
NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide
Journal of Clinical Oncology, 11/12/09
Sponsor
Article Search
Sponsor
Sponsor